Left ventricular remodeling in patients with metabolic syndrome: influence of gender.

[1]  Philippe Van De Borne,et al.  Guidelines for the management of arterial hypertension , 2014 .

[2]  B. Howard,et al.  Sex differences in obesity-related changes in left ventricular morphology: the Strong Heart Study , 2011, Journal of hypertension.

[3]  Lawrence Joseph,et al.  The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. , 2010, Journal of the American College of Cardiology.

[4]  Daniel Levy,et al.  Relation of Disease Pathogenesis and Risk Factors to Heart Failure With Preserved or Reduced Ejection Fraction: Insights From the Framingham Heart Study of the National Heart, Lung, and Blood Institute , 2009, Circulation.

[5]  G. Mancia,et al.  Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population , 2008, Journal of hypertension.

[6]  G. Cerasola,et al.  Relationships between metabolic syndrome and left ventricular mass in hypertensive patients: does sex matter? , 2008, Journal of Human Hypertension.

[7]  G. Mancia,et al.  Metabolic syndrome and multiple organ damage in essential hypertension , 2008, Blood Pressure.

[8]  Yun-dai Chen,et al.  Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia , 2008, Heart and Vessels.

[9]  F. Cuccurullo,et al.  Prognostic relevance of metabolic syndrome in hypertensive patients at low-to-medium risk. , 2007, American journal of hypertension.

[10]  R. Devereux,et al.  Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study , 2007, Journal of Human Hypertension.

[11]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[12]  G. Mancia,et al.  Age and target organ damage in essential hypertension: role of the metabolic syndrome. , 2007, American journal of hypertension.

[13]  G. Bakris,et al.  Gender disparity in outcomes of care and management for diabetes and the metabolic syndrome , 2006, Current diabetes reports.

[14]  E. Mannarino,et al.  Different Impact of the Metabolic Syndrome on Left Ventricular Structure and Function in Hypertensive Men and Women , 2006, Hypertension.

[15]  William Stewart,et al.  Recommendations for chamber quantification. , 2006, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[16]  A. Grandi,et al.  Metabolic syndrome and morphofunctional characteristics of the left ventricle in clinically hypertensive nondiabetic subjects. , 2006, American journal of hypertension.

[17]  Fernando Costa,et al.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. , 2005, Circulation.

[18]  G. Cerasola,et al.  Influence of metabolic syndrome on hypertension‐related target organ damage , 2005, Journal of internal medicine.

[19]  B. Paulweber,et al.  The Metabolic Syndrome Is a Stronger Risk Factor for Early Carotid Atherosclerosis in Women Than in Men , 2005, Stroke.

[20]  Ken Williams,et al.  National Cholesterol Education Program Versus World Health Organization Metabolic Syndrome in Relation to All-Cause and Cardiovascular Mortality in the San Antonio Heart Study , 2004, Circulation.

[21]  E. Mannarino,et al.  Prognostic value of the metabolic syndrome in essential hypertension. , 2004, Journal of the American College of Cardiology.

[22]  R. Schmieder,et al.  A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. , 2003, The American journal of medicine.

[23]  G. de Simone,et al.  Prognostic significance of left ventricular diastolic dysfunction in essential hypertension. , 2002, Journal of the American College of Cardiology.

[24]  C Cosco,et al.  Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. , 2000, Hypertension.

[25]  Giuseppe Mancia,et al.  Ambulatory Blood Pressure Is Superior to Clinic Blood Pressure in Predicting Treatment-Induced Regression of Left Ventricular Hypertrophy , 1997 .

[26]  S. Daniels,et al.  Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. , 1992, Journal of the American College of Cardiology.

[27]  P. Allhoff,et al.  San Antonio Heart Study , 1991 .

[28]  N. Reichek,et al.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.

[29]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.